Conversion to Sirolimus in Kidney-Pancreas and Pancreas Transplantation

Transplantation Proceedings

Volumn 40, Issue 10, 2008, Pages 3601-3605

  Matias, P ^a,b   Araujo, M R ^a   Romao Jr J E ^a   Abensur, H ^a   Noronha, I L ^a,c  

^a HOSPITAL BENEFICÊNCIA PORTUGUESA DE SÃO PAULO   (Brazil)

^b HOSPITAL DE SANTA CRUZ   (Portugal)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; C PEPTIDE; CREATININE; CYCLOSPORIN A; DACLIZUMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ACNE; ACUTE GRAFT REJECTION; ADULT; ARTICLE; BONE MARROW SUPPRESSION; CHOLESTEROL BLOOD LEVEL; CLINICAL EVALUATION; CREATININE BLOOD LEVEL; DIARRHEA; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSLIPIDEMIA; FEMALE; GASTROINTESTINAL SYMPTOM; GRAFT REJECTION; HEALTH STATUS; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY PANCREAS TRANSPLANTATION; LEUKOENCEPHALOPATHY; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; NEUROTOXICITY; OUTCOME ASSESSMENT; PANCREAS GRAFT REJECTION; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; PROTEINURIA; RETROSPECTIVE STUDY; SIDE EFFECT; STOMACH PARESIS; SURGICAL PATIENT; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; CALCINEURIN; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; HYPERGLYCEMIA; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PANCREAS TRANSPLANTATION; RETROSPECTIVE STUDIES; SIROLIMUS; YOUNG ADULT;

EID: 57549106616     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.07.138     Document Type: Article

References (18)

1. Gruessner A.C., and Sutherland D.E. Pancreas transplant outcomes for United States (US) cases reported to the United Network for Organ Sharing (UNOS) and non-US cases reported to the International Pancreas Transplant Registry (IPTR) as of October, 2000. Clin Transpl (2000) 45
2. Demartines N., Schiesser M., and Clavien P.A. An evidence-based analysis of simultaneous pancreas-kidney and pancreas transplantation alone. Am J Transplant 5 (2005) 2688
3. Tamura K., Fujimura T., Tsutsumi T., et al. Transcriptional inhibition of insulin by FK506 and possible involvement of FK506 binding protein-12 in pancreatic beta-cell. Transplantation 59 (1995) 1606
4. Abramowicz D., Wissing K.M., and Broeders N. Nephrotoxicity of calcineurin inhibitors: new therapeutic approaches. Transplant Proc 32 1A suppl (2000) 3S
5. Garcia V.D., Keitel E., Santos A.F., et al. Immunosuppression in pancreas transplantation: mycophenolate mophetil versus sirolimus. Transplant Proc 36 (2004) 975
6. Ikonen T.S., Gummert J.F., Hayase M., et al. Sirolimus (Rapamycin) halts and reverses progression on allograft vascular disease in non-human primates. Transplantation 70 (2000) 969
7. Diekmann F., Waiser J., Fritsche L., et al. Conversion to rapamycin in renal allograft recipients with biopsy-proven calcineurin inhibitor-induced nephrotoxicity. Transplant Proc 33 (2001) 3234
8. Bumbea V., Kamar N., Ribes D., et al. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus. Nephrol Dial Transplant 20 (2005) 2517
9. Vincenti F., and Stock P. De novo use of sirolimus in immunosuppression regimens in kidney and kidney-pancreas transplantation at the University of California, San Francisco. Transplant Proc 35 (2003) 183S
10. Rogers J., Ashcraft E.E., Emovon O.E., et al. Long-term outcome of sirolimus rescue in kidney-pancreas transplantation. Transplantation 78 (2004) 619
11. Almeida M., Martins L.S., Dias L., et al. Conversion to sirolimus in a population of kidney and kidney-pancreas transplant recipients. Transplant Proc 37 (2005) 2777
12. Knight R.J., Kerman R.H., McKissick E., et al. A pilot study of immunosuppression minimization after pancreas-kidney transplantation utilizing thymoglobulin induction and sirolimus maintenance therapy. Transplant Proc 37 (2005) 3538
13. Stegall M.D., Kim D.Y., Prieto M., et al. Thymoglobulin induction decreases rejection in solitary pancreas transplantation. Transplantation 72 (2001) 1671
14. Sutherland D.E., Gruessner R., Kandswamy R., et al. Beta-cell replacement therapy (pancreas and islet transplantation) for treatment of diabetes mellitus: an integrated approach. Transplant Proc 36 (2004) 1697
15. Noronha I.L., Oliveira S.G., Tavares T.S., et al. Apoptosis in kidney and pancreas allograft biopsies. Transplantation 79 (2005) 1231
16. Nankivell B.J., Borrows R.J., Fung C.L., et al. The natural history of chronic allograft nephropathy. N Engl J Med 349 (2003) 2326
17. Mulay A.V., Cockfield S., Stryker R., et al. Conversion from calcineurin inhibitors to sirolimus for chronic renal allograft dysfunction: a systematic review of the evidence. Transplantation 82 (2006) 1153
18. Fernandez L., Lehmann R., Luzi L., et al. The effects of maintenance doses of FK 506 versus Cyclosporin A on glucose and lipid metabolism after orthotopic liver transplantation. Transplantation 68 (1999) 1532